MEDICINAL FORMS OF HIGH DOSAGE Russian patent published in 1999 - IPC

Abstract RU 2135182 C1

FIELD: pharmacy. SUBSTANCE: invention relates to the improved oral pharmaceutical medicinal forms of high dosage of an active substance. An active substance is mycophenolatemophetyl, mycophenolic acid or ranolazine. Indicated active substance is in a liquid state obtained by its heating to the point above its melting point followed by cooling to the point below its melting point. In preferable variant the oral pharmaceutical medicinal form is made as a capsule and contains therapeutically effective amount of mycophenolatemophetyl in liquid state obtained by heating to the first temperature above 95 C followed by cooling to the second temperature below 80 C. EFFECT: improved indices of availability of an active substance, decreased daily doses of drug intake by patients. 19 cl, 6 ex

Similar patents RU2135182C1

Title Year Author Number
ORAL SUSPENSION CONTAINING HIGH DOSE OF MOFETIL MYCOPHENOLATE 1994
  • Debora M. Lidgejt
  • Li-Khua Vang-Kessler
  • Bindu Dzhoshi
  • Saje Dzh. Khedzh
  • Leo Gu
RU2150942C1
RANOLAZINE PREPARATIONS WITH PROLONGED EFFECT 1999
  • Vol'Ff Ehndrju A.
  • Behjker Fiona
  • Lehngridzh Dzhon
RU2214233C2
DERIVATIVES OF 10,11-METHANEDIBENZOSUBERANE, CHEMOSENSIBILIZING COMPOSITION, METHOD RESISTANCE TO ANTITUMOR DRUG OVERCOMING AND METHOD OF TREATMENT OF PATIENTS WITH TUMOR DISEASES 1994
  • Jurg Roland Pfister
  • Doris Linn Slejt
RU2167154C2
ANHYDROUS CRYSTALLINE MOFETYL MICOPHENOLATE, INTRAVENOUS COMPOSITION BASED THEREOF, AND FORMULATION SUITABLE FOR PREPARING INTRAVENOUS AQUEOUS COMPOSITION 1994
  • Rozher Cherng Fu
  • De-Mej Leung
  • Dzheffri S.Flejtman
  • Mikele S.Rizzolio
RU2132849C1
DIMETANSULPHONATE N-HYDROXY-4{5-[4-(5-ISOPROPYL-2-METHYL-1,3-THIAZOL-4-YL)PHENOXY]PENTOXY}BENZAMIDINE 2005
  • Riu Dzej Mehn
  • Li Dzin Soo
  • Shin Dong Khiuk
  • Seong Seung Kioo
  • Cho Soon Ki
  • Dzeon Chan Seok
  • Dzin Jang Goo
  • Li Ki Jang
  • Dzung Se Khiun
  • Cho Eun Khee
  • Akhn Seok Khoon
RU2361867C2
PHARMACEUTICAL FORMULATIONS OF HIF HYDROXYLASE INHIBITORS 2014
  • Konka Devid
  • Flippin Li Allen
  • Lej Skott Devid
  • Vitshi Klaudiya
  • Rajt Li Robert
RU2681304C2
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED COMPOSITION CONTAINING GLUCOKINASE ACTIVATOR AND BIGUANIDE HYPOGLYCEMIC DRUG, AS WELL AS THEIR PREPARATION METHOD, AND THEIR USE 2019
  • Chen, Li
  • Li, Yongguo
  • Wang, Gaosen
RU2780377C2
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED COMPOSITION, CONTAINING GLUCOKINASE ACTIVATOR AND PPAR RECEPTOR ACTIVATOR, AND THEIR PREPARATION METHOD, AND THEIR USE 2019
  • Chen, Li
  • Li, Yongguo
  • Wang, Gaosen
  • Gao, Huisheng
RU2781638C2
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED FORMULATION CONTAINING A GLUCOKINASE ACTIVATOR AND A KATP CHANNEL BLOCKER, METHOD FOR PRODUCTION AND APPLICATION THEREOF 2019
  • Chen, Li
  • Li, Yungo
  • Van, Gaosen
  • Gao, Khuejshen
RU2772875C1
PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED FORMULATION CONTAINING A GLUCOKINASE ACTIVATOR AND AN SGLT-2 INHIBITOR, AND METHODS FOR PRODUCTION AND APPLICATION THEREOF 2019
  • Chen, Li
  • Li, Yongguo
  • Wang, Gaosen
  • Gao, Huisheng
RU2770043C1

RU 2 135 182 C1

Authors

Glenn Dzhej Samuels

Jang-Chang Li

Charl'Z Li

Stiven Berri

Pol Dzhozef Jarots

Dates

1999-08-27Published

1994-05-10Filed